Tandem Diabetes Care (TNDM)Rep. Gilbert Cisneros (CA31) disclosed a purchase $1K–$15K
Rep. Gilbert Cisneros (CA31) disclosed a purchase of Tandem Diabetes Care in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 35 days
- Disclosure lag
- Traded
- Mar 3, 2026
- Disclosed
- Apr 7, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 19, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 23, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
- Mar 3, 2026 · this disclosureCongressDisclosed purchase of TNDM — reported range $1,001 - $15,000
What came next
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 11, 2026, Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the “Company”), was notified that his employment with the Company is being terminated without cause.”
- May 20, 2026Company filing · Form 8-K · Shareholder rights, Executive changeChanged a top executive or board member, and changed the rights of its shareholders (and 1 more item)“At the Annual Meeting, the Company’s stockholders also approved the Company’s 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares of the Company’s common stock (Common Stock) authorized for issuance under the plan by 3,260,000 shares (as so amended, the Amended Plan).”
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Tandem Diabetes Care
For Tandem Diabetes Care, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TNDM page.
Other recent filings by Rep. Gilbert Cisneros (CA31)
- House Clerk periodic transaction report at Globus Medical (GMED)Sep 10, 2026
- House Clerk periodic transaction report at Horace Mann Educators Corporation (HMN)Sep 10, 2026
- House Clerk periodic transaction report at Insulet Corporation (PODD)Sep 10, 2026
- House Clerk periodic transaction report at NXP Semiconductors (NXPI)Sep 10, 2026
- House Clerk periodic transaction report at Tesla (TSLA)Sep 10, 2026
The full history of Rep. Gilbert Cisneros (CA31) is on the profile page.
How this filing works
Other disclosures at Tandem Diabetes Care
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HROct 28, 2025
Everything OQRO holds on this company is on its TNDM page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
